U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07013760) titled 'Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain' on April 04.
Brief Summary: Observational retrospective study to characterize and assess clinical outcomes of patients receiving tezepelumab after marketing approval in Spain
Study Start Date: June 30
Study Type: OBSERVATIONAL
Condition:
Asthma
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AstraZeneca
Published by HT Digital Content Services with permission from Health Daily Digest....